KPV Peptide

The KPV peptide is the three-amino-acid sequence lysine-proline-valine, also written as Lys-Pro-Val or K-P-V. It corresponds to residues 11–13 at the C-terminus of alpha-melanocyte-stimulating hormone. This lineage identifies the final three residues of alpha-MSH; it does not make the KPV tripeptide the full 13-residue molecule or transfer every property reported for full-length alpha-MSH.

Reborn catalogues the article under SKU KP10, with “kpv 10mg” used as its catalogue entry. This wording is not a verified fill quantity or presentation. Amount and physical form remain subject to reconciliation across the released label, product specification and Certificate of Analysis for the applicable batch.

Reference identifiers must be read against the offered molecular form and batch documents. They do not authenticate supplied material, and salt or other form-specific information may be stated only when released documentation supports it.

Identity and lineage sources: Getting et al. 2003 · PMID 12750433 · Bonfiglio et al. 2006 · PMID 16965771

PepT1-mediated uptake describes transport through the peptide transporter examined in defined intestinal epithelial, immune-cell and murine systems. Dalmasso and colleagues connected this transport question with NF-kappaB activation, MAP-kinase activation and cytokine-response measurements in in vitro intestinal epithelial and immune-cell models and murine colitis models. Viennois and colleagues examined PepT1 dependence through wild-type and knockout mice in a murine colitis-associated carcinogenesis model.

Land examined p65RelA nuclear import, NF-kappaB signalling, importin-alpha3 and melanocortin-related signalling in an in vitro human bronchial epithelial-cell model under specified stimuli. Sung and colleagues measured reactive oxygen species, IL-1beta, viability and MAPK/NF-kappaB endpoints in in vitro human keratinocytes and three-dimensional skin models exposed to fine particulate matter. These are mechanistic endpoints within their named systems, not human outcomes.

Xiao and colleagues used hyaluronic-acid-functionalised nanoparticles and a hydrogel system in cell-uptake work and a murine colitis model. Carrier and formulation are integral to those findings, which cannot be assigned to unformulated KPV material.

Mechanism sources: Dalmasso et al. 2008 · PMID 18061177 · Viennois et al. 2016 · PMID 27458604 · Land 2012 · PMID 22837805 · Sung et al. 2025 · PMID 40073467 · Xiao et al. 2017 · PMID 28143741

This section describes findings in controlled research and makes no statement about use. The records must be read by model, species, stressor, transport system, method and measured endpoint; they do not form a body of human intervention evidence.

Two further murine records refine, rather than remove, these boundaries. Kannengiesser and colleagues measured body-weight recovery and inflammatory infiltrates in two murine colitis models. Xiao and colleagues measured targeted cellular uptake, mucosal markers and TNF-alpha in a carrier-dependent nanoparticle and hydrogel system used in a murine colitis model.

Additional study sources: Kannengiesser et al. 2008 · PMID 18092346 · Xiao et al. 2017 · PMID 28143741

KPV, K-P-V and Lys-Pro-Val name the same three-residue sequence. “alpha-MSH 11–13” describes its lineage, not full-length alpha-MSH. Sequence ancestry does not imply that KPV reproduces every property or signalling interaction reported for the full 13-residue molecule.

GHK-Cu is a copper(II) complex of the Gly-His-Lys sequence. KPV is Lys-Pro-Val and carries no copper designation; sequence, chemical identity and literature record differ. KPV is also a declared component of KLOW, but a component relationship does not transfer findings from isolated KPV to the combined composition. VIP is a separately catalogued peptide with a different molecule, literature record and batch documentation despite its similar-looking abbreviation.

Suppliers in this market list KPV at 500 mcg, 5 mg and 10 mg, and further offer capsule and other oral presentations. This spread is a neutral format distinction: a declared amount or presentation from one supplier establishes nothing about another material. For Reborn, “kpv 10mg” is only the catalogue designation under KP10 until amount and presentation are reconciled with released documentation.

Delimitation sources: Getting et al. 2003 · PMID 12750433 · Luger et al. 2007 · PMID 17934097

Amount and physical form are not established in this record. The binding sources are the released label, product specification and applicable batch documentation. The same sources must provide any storage temperature, light-protection requirement, stability period or other condition; no temperature value is asserted here. Laboratory inventory records should preserve the product designation, SKU, batch code and related analytical documents together.

Every released batch should have an attributable Certificate of Analysis linked through the KPV product name and batch code. The certificate should identify the tested material, test date, reported amount, analytical method and result. A certificate without a matching product name and batch code cannot substantiate the offered material.

HPLC may document a chromatographic profile and a numerical purity finding only for the tested batch and within the stated method. This record makes no blanket purity claim. HPLC alone may not settle every identity or quantity question, so its result must be read with the label, specification and any other identity method reported for that batch.

Analytical boundary illustrated by formulated research: Xiao et al. 2017 · PMID 28143741

KPV is supplied to laboratories in the EU as research material. Procurement review should reconcile the precise Lys-Pro-Val identity, catalogue entry, label, specification, matching batch code, attributable COA and documented analytical methods before material is assigned to a controlled study. Laboratories that buy KPV receive research material only, within the documentation boundary described above.

The literature supplies a model-specific framework spanning PepT1 transport, signalling, epithelial, antimicrobial and animal measurements. It neither demonstrates a combined human outcome nor verifies commercial material. Product identity, amount, physical form, storage conditions and any numerical purity statement require the applicable released batch documentation.

Research use only. For laboratory research only. Not for human or veterinary use. Not intended to diagnose, treat, cure or prevent any disease. Not a medicinal product, food or cosmetic.